The Patent Finder

Dingfu Biotarget Co., Ltd.

Also on record
Records under this name other than patents Dingfu Biotarget Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Dingfu Biotarget Co., Ltd.

PatentTitleStatus Expires Confidence
US 10,471,124Proteinaceous heterodimer and use thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,357,826IL-10 EGFR antibody fusion protein and uses thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,624,974Anti-OX40 antibody and application thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,875,926Fully human antibody against human CD 137
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,795,230ANTI-CD27 Antibodies and Use Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,529,425Immunoconjugates comprising signal regulatory protein alpha
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,845,806Proteinaceous heterodimer and use thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,987,609Proteinaceous heterodimer and use thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,883,503Methods and compositions for cancer treatment
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,252,542Anti-CD137 antibodies and method of treating colorectal cancer using them
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited